https://orcid.org/0000-0003-1596-0998
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Julie Le Naour, Léa Montégut, Yuhong Pan, Sarah Adriana Scuderi, Pierre Cordier, Adrien Joseph, Allan Sauvat, Valerio Iebba, Juliette Paillet, Gladys Ferrere, Ludivine Brechard, Claire Mulot, Grégory Dubourg, Laurence Zitvogel, Jonathan G. Pol, Erika Vacchelli, Pierre-Laurent Puig & Guido Kroemer. (2023) Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis. OncoImmunology 12:1.
Read now
Read now
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M. Borras, Lisa Kinget, Jitka Fucíková, Radek Špíšek, Lenka Palová Jelínková, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, An Coosemans, Rianne D.W. Vaes, Dirk De Ruysscher, Steven De Vleeschouwer, Els Wauters, Evelien Smits, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, Hans Wildiers, Paul M. Clement, Peter Vandenabeele, Laurence Zitvogel & Abhishek D. Garg. (2023) Trial watch: chemotherapy-induced immunogenic cell death in oncology. OncoImmunology 12:1.
Read now
Read now
Articles from other publishers (19)
Liangyu Zhang, Maohao Guan, Xun Zhang, Fengqiang Yu & Fancai Lai. (2023) Machine-learning and combined analysis of single-cell and bulk-RNA sequencing identified a DC gene signature to predict prognosis and immunotherapy response for patients with lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology 149:15, pages 13553-13574.
Crossref
Crossref
Sajal Sen, Krystle Karoscik, Esther Maier & Jonathan F. Arambula. (2023) Immunogenic cell death-inducing metal complexes: From the benchtop to the clinic. Current Opinion in Chemical Biology 73, pages 102277.
Crossref
Crossref
Yamei Chen, Shihao Zhu, Tianyuan Liu, Shaosen Zhang, Junting Lu, Wenyi Fan, Lin Lin, Tao Xiang, Jie Yang, Xuan Zhao, Yiyi Xi, Yuling Ma, Guoyu Cheng, Dongxin Lin & Chen Wu. (2023) Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell.
Crossref
Crossref
Xiaofan Mao, Dan Zhou, Kairong Lin, Beiying Zhang, Juntao Gao, Fei Ling, Lewei Zhu, Sifei Yu, Peixian Chen, Chuling Zhang, Chunguo Zhang, Guolin Ye, Simon Fong, Guoqiang Chen & Wei Luo. (2022) Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer. Cancer Immunology, Immunotherapy 72:3, pages 679-695.
Crossref
Crossref
Milica Živanić, Albert Espona‐Noguera, Abraham Lin & Cristina Canal. (2023) Current State of Cold Atmospheric Plasma and Cancer‐Immunity Cycle: Therapeutic Relevance and Overcoming Clinical Limitations Using Hydrogels. Advanced Science 10:8.
Crossref
Crossref
Shuai Zhang, Liwei Zhao, Hui Chen, Guido Kroemer, Peng Liu & Oliver Kepp. 2023. Radiation Oncology and Radiotherapy. Radiation Oncology and Radiotherapy
65
73
.
Michelle A. Hsu, Stephanie M. Okamura, C. Daniel De Magalhaes Filho, Daniele M. Bergeron, Ahiram Rodriguez, Melissa West, Deepak Yadav, Roger Heim, Jerry J. Fong & Miguel Garcia-Guzman. (2022) Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model. Cancer Immunology, Immunotherapy 72:1, pages 151-168.
Crossref
Crossref
Juliette Humeau, Julie Le Naour, Guido Kroemer & Jonathan G. Pol. 2023.
Enar Jumaniyazova, Daniil Smyk, Polina Vishnyakova, Timur Fatkhudinov & Konstantin Gordon. (2022) Photon- and Proton-Mediated Biological Effects: What Has Been Learned?. Life 13:1, pages 30.
Crossref
Crossref
Yizhu Yao, Liudan Gu, Ziyi Zuo, Dandan Wang, Tianlin Zhou, Xiaomei Xu, Lehe Yang, Xiaoying Huang & Liangxing Wang. (2022) Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Megan Johnstone, Delaney Vinaixa, Marcello Turi, Eugenio Morelli, Kenneth Carl Anderson & Annamaria Gulla. (2022) Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma. Cells 11:16, pages 2519.
Crossref
Crossref
Mosar Corrêa Rodrigues, José Athayde Vasconcelos Morais, Rayane Ganassin, Giulia Rosa Tavares Oliveira, Fabiana Chagas Costa, Amanda Alencar Cabral Morais, Ariane Pandolfo Silveira, Victor Carlos Mello Silva, João Paulo Figueiró Longo & Luis Alexandre Muehlmann. (2022) An Overview on Immunogenic Cell Death in Cancer Biology and Therapy. Pharmaceutics 14:8, pages 1564.
Crossref
Crossref
Lauren Kelly, Sarah McGrath, Lewis Rodgers, Kathryn McCall, Aysin Tulunay Virlan, Fiona Dempsey, Scott Crichton & Carl S. Goodyear. (2022) Annexin‐A1: The culprit or the solution?. Immunology 166:1, pages 2-16.
Crossref
Crossref
Guido Kroemer, Claudia Galassi, Laurence Zitvogel & Lorenzo Galluzzi. (2022) Immunogenic cell stress and death. Nature Immunology 23:4, pages 487-500.
Crossref
Crossref
Ornella Franzese, Francesco Torino, Elisa Giannetti, Giorgia Cioccoloni, Angelo Aquino, Isabella Faraoni, Maria Pia Fuggetta, Liana De Vecchis, Anna Giuliani, Bernd Kaina & Enzo Bonmassar. (2021) Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?. International Journal of Molecular Sciences 22:19, pages 10672.
Crossref
Crossref
Thomas Grewal, Carles Rentero, Carlos Enrich, Mohamed Wahba, Carsten A. Raabe & Ursula Rescher. (2021) Annexin Animal Models—From Fundamental Principles to Translational Research. International Journal of Molecular Sciences 22:7, pages 3439.
Crossref
Crossref
Masanori Oshi, Yoshihisa Tokumaru, Swagoto Mukhopadhyay, Li Yan, Ryusei Matsuyama, Itaru Endo & Kazuaki Takabe. (2021) Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer. Cells 10:3, pages 653.
Crossref
Crossref
Julie Le Naour, Peng Liu, Liwei Zhao, Sandy Adjemian, Zsofia Sztupinszki, Julien Taieb, Claire Mulot, Aymeric Silvin, Charles-Antoine Dutertre, Florent Ginhoux, Allan Sauvat, Giulia Cerrato, Francesca Castoldi, Isabelle Martins, Gautier Stoll, Juliette Paillet, Khady Mangane, Cornelia Richter, Oliver Kepp, Maria Chiara Maiuri, Federico Pietrocola, Peter Vandenabeele, Fabrice André, Suzette Delaloge, Zoltan Szallasi, Pierre Laurent-Puig, Jessica Zucman-Rossi, Laurence Zitvogel, Jonathan G. Pol, Erika Vacchelli & Guido Kroemer. (2021) A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency. Cancer Discovery 11:2, pages 408-423.
Crossref
Crossref
Jacques Rouanet, Valentin Benboubker, Hussein Akil, Ana Hennino, Philippe Auzeloux, Sophie Besse, Bruno Pereira, Solène Delorme, Sandrine Mansard, Michel D’Incan, Françoise Degoul & Paul-Olivier Rouzaire. (2020) Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy. Cancer Immunology, Immunotherapy 69:10, pages 2075-2088.
Crossref
Crossref